US Distribution Partner Medinol recently secured a U.S. distribution agreement for EluNIR with CoSo Health, signaling openness to distribution partnerships to push DES adoption in the U.S. This presents an opportunity to identify additional distributors in key regions, explore exclusive or nonexclusive arrangements, and equip partner networks with training and marketing collateral to drive adoption.

Superior Deliverability EluNIR features a Flexx2 catheter with a metallic spring tip and a low metal footprint elastomeric coating, enabling easier delivery in challenging anatomies and strong clinical performance. Target high-volume cath labs performing complex interventions with tailored clinical cases, training, and collaborative trials to accelerate uptake.

In House Quality Medinol manufactures in house using proprietary technologies to ensure consistently high quality and safety. Emphasize supply chain reliability to procurement teams, offer favorable lead times or stocking programs, and present a robust risk mitigation plan to large health systems seeking dependable DES supply.

Clear Regulatory Path EluNIR is FDA approved and CE marked, with clinical studies supporting safety. Leverage the regulatory status and clinical evidence when engaging KOLs and hospitals, explore additional registry or comparative study opportunities, and strengthen RFP responses with clear evidence of clearance and performance.

Competitive Differentiation The unique elastomeric coating and ease of deliverability position EluNIR as a differentiator in the DES market. Use this to craft a value proposition focused on reduced procedure time, safety, and deliverability, and pursue clinical and ROI-focused materials to win contracts against peers.